Iżycka-Świeszewska E - Search Results

1

Complexity of Neural Component of Tumor Microenvironment in Prostate Cancer.

Sejda A, Sigorski D, Gulczyński J, Wesołowski W, Kitlińska J, Iżycka-Świeszewska E. Sejda A, et al. Pathobiology. 2020;87(2):87-99. doi: 10.1159/000505437. Epub 2020 Feb 11. Pathobiology. 2020. PMID: 32045912 Free article. Review.

2

Short history of the autopsy. Part I. From prehistory to the middle of the 16th century.

Gulczyński J, Izycka-Swieszewska E, Grzybiak M. Gulczyński J, et al. Pol J Pathol. 2009;60(3):109-14. Pol J Pathol. 2009. PMID: 20069503 Free article.

3

Short history of the autopsy: part II. From the second half of the 16th century to contemporary times.

Gulczyński J, Iżycka-Świeszewska E, Grzybiak M. Gulczyński J, et al. Pol J Pathol. 2010;61(3):169-75. Pol J Pathol. 2010. PMID: 21225501 Free article.

4

Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: implications for tumor biology and therapy.

Lu C, Tilan JU, Everhart L, Czarnecka M, Soldin SJ, Mendu DR, Jeha D, Hanafy J, Lee CK, Sun J, Izycka-Swieszewska E, Toretsky JA, Kitlinska J. Lu C, et al. J Biol Chem. 2011 Aug 5;286(31):27494-505. doi: 10.1074/jbc.M111.224089. Epub 2011 Jun 16. J Biol Chem. 2011. PMID: 21680731 Free PMC article.

5

Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.

Tilan JU, Lu C, Galli S, Izycka-Swieszewska E, Earnest JP, Shabbir A, Everhart LM, Wang S, Martin S, Horton M, Mahajan A, Christian D, O'Neill A, Wang H, Zhuang T, Czarnecka M, Johnson MD, Toretsky JA, Kitlinska J. Tilan JU, et al. Oncotarget. 2013 Dec;4(12):2487-501. doi: 10.18632/oncotarget.1604. Oncotarget. 2013. PMID: 24318733 Free PMC article.

6

Cancer metastases to meningioma: apropos two cases.

Iżycka-Świeszewska E, Czapiewski P, Szurowska E, Borof D, Wesołowski W, Kloc W. Iżycka-Świeszewska E, et al. Folia Neuropathol. 2013;51(4):340-6. doi: 10.5114/fn.2013.39725. Folia Neuropathol. 2013. PMID: 24374963 Free article.

7

Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.

Czarnecka M, Trinh E, Lu C, Kuan-Celarier A, Galli S, Hong SH, Tilan JU, Talisman N, Izycka-Swieszewska E, Tsuei J, Yang C, Martin S, Horton M, Christian D, Everhart L, Maheswaran I, Kitlinska J. Czarnecka M, et al. Oncogene. 2015 Jun 11;34(24):3131-43. doi: 10.1038/onc.2014.253. Epub 2014 Aug 18. Oncogene. 2015. PMID: 25132261 Free PMC article.

8

Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.

Tilan JU, Krailo M, Barkauskas DA, Galli S, Mtaweh H, Long J, Wang H, Hawkins K, Lu C, Jeha D, Izycka-Swieszewska E, Lawlor ER, Toretsky JA, Kitlinska JB. Tilan JU, et al. Cancer. 2015 Mar 1;121(5):697-707. doi: 10.1002/cncr.29090. Epub 2014 Nov 11. Cancer. 2015. PMID: 25387699 Free PMC article.

9

High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases.

Hong SH, Tilan JU, Galli S, Izycka-Swieszewska E, Polk T, Horton M, Mahajan A, Christian D, Jenkins S, Acree R, Connors K, Ledo P, Lu C, Lee YC, Rodriguez O, Toretsky JA, Albanese C, Kitlinska J. Hong SH, et al. Oncotarget. 2015 Mar 30;6(9):7151-65. doi: 10.18632/oncotarget.3345. Oncotarget. 2015. PMID: 25714031 Free PMC article.

10

Extracardiac rhabdomyomas--presentation of two cases with analysis of AKT/mTOR and ERK1/2 signaling.

Iżycka-Świeszewska E, Wesołowski W, Hermann B. Iżycka-Świeszewska E, et al. Pol J Pathol. 2015 Jun;66(2):195-9. doi: 10.5114/pjp.2015.53016. Pol J Pathol. 2015. PMID: 26247533 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page